Structure-Property Optimization of a Series of Imidazopyridines for Visceral Leishmaniasis.


Journal

ACS infectious diseases
ISSN: 2373-8227
Titre abrégé: ACS Infect Dis
Pays: United States
ID NLM: 101654580

Informations de publication

Date de publication:
11 08 2023
Historique:
medline: 14 8 2023
pubmed: 7 7 2023
entrez: 7 7 2023
Statut: ppublish

Résumé

Leishmaniasis is a collection of diseases caused by more than 20

Identifiants

pubmed: 37417544
doi: 10.1021/acsinfecdis.3c00040
pmc: PMC10425983
doi:

Substances chimiques

imidazopyridine 0
Imidazoles 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S. Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1470-1487

Subventions

Organisme : NIAID NIH HHS
ID : R33 AI141227
Pays : United States

Références

Expert Opin Ther Pat. 2014 Oct;24(10):1067-75
pubmed: 25069517
Nat Rev Drug Discov. 2015 Nov;14(11):751-8
pubmed: 26435527
J Med Chem. 2002 Feb 28;45(5):999-1001
pubmed: 11855979
ChemMedChem. 2007 Aug;2(8):1100-15
pubmed: 17530727
Eur J Med Chem. 2012 Nov;57:441-8
pubmed: 22840492
Drug Discov Today. 2004 Dec 1;9(23):1020-8
pubmed: 15574318
J Med Chem. 2020 Jun 25;63(12):6276-6302
pubmed: 31497963
Ther Adv Psychopharmacol. 2015 Feb;5(1):26-31
pubmed: 25653828
Nat Biotechnol. 2016 Jan;34(1):95-103
pubmed: 26501955
J Med Chem. 2001 Apr 26;44(9):1313-33
pubmed: 11311053
J Glob Infect Dis. 2010 May;2(2):151-8
pubmed: 20606971
RSC Med Chem. 2021 Jan 21;12(3):384-393
pubmed: 34041487
Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43
pubmed: 19934256
J Am Chem Soc. 2002 May 29;124(21):6043-8
pubmed: 12022838
Trop Med Infect Dis. 2019 Mar 02;4(1):
pubmed: 30832380
Lancet. 2009 May 2;373(9674):1570-5
pubmed: 19410718

Auteurs

Maria Dichiara (M)

Department of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts 02115, United States.

Quillon J Simpson (QJ)

Department of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts 02115, United States.

Antonio Quotadamo (A)

Department of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts 02115, United States.

Hitesh B Jalani (HB)

Department of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts 02115, United States.

Anson X Huang (AX)

Department of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts 02115, United States.

Caroline C Millard (CC)

Department of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts 02115, United States.

Dana M Klug (DM)

School of Pharmacy, University College London, London WC1N 1AX, U.K.

Edwin G Tse (EG)

School of Pharmacy, University College London, London WC1N 1AX, U.K.

Matthew H Todd (MH)

School of Pharmacy, University College London, London WC1N 1AX, U.K.

Daniel Gedder Silva (DG)

School of Pharmacy, University College London, London WC1N 1AX, U.K.
School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo 14040-903, Brazil.

Flavio da Silva Emery (F)

School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo 14040-903, Brazil.

J Eric Carlson (JE)

Rilas Technologies, Inc, 150-W New Boston Street, Woburn, Massachusetts 01801, United States.

Shao-Liang Zheng (SL)

Department of Chemistry and Chemical Biology, Harvard University, Cambridge, Massachusetts 02138, United States.

Margot Vleminckx (M)

Laboratory of Microbiology, Parasitology and Hygiene (LMPH), University of Antwerp, 2610 Wilrijk, Belgium.

An Matheeussen (A)

Laboratory of Microbiology, Parasitology and Hygiene (LMPH), University of Antwerp, 2610 Wilrijk, Belgium.

Guy Caljon (G)

Laboratory of Microbiology, Parasitology and Hygiene (LMPH), University of Antwerp, 2610 Wilrijk, Belgium.

Michael P Pollastri (MP)

Department of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts 02115, United States.

Peter Sjö (P)

Drugs for Neglected Diseases Initiative, 15 Chemin Camille Vidart, Geneva 1202, Switzerland.

Benjamin Perry (B)

Drugs for Neglected Diseases Initiative, 15 Chemin Camille Vidart, Geneva 1202, Switzerland.

Lori Ferrins (L)

Department of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts 02115, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH